Frances K. Heller

Frances K.
Heller is the founder of Good2Go, Inc. which was founded in 2015.
She is currently a Co-Chairman at Lava Mae, a Director at Diagnostics for All since 2015, a Director at Affinivax, Inc. since 2014, and an Independent Director at Monterey Innovation Acquisition Corp.
since 2021.
Ms. Heller's former jobs include being a Director at Zafgen, Inc. from 2011 to 2012, an Independent Director at Zafgen, Inc. from 2014 to 2018, a Director at Adimab LLC, a Director at NeuroTherapeutics Pharma, Inc., a Senior Vice President-Business Development at Bristol Myers Squibb Co., a VP-Corporate Development & Legal Affairs at Signature BioScience, Inc. from 2001 to 2003, a Trustee at Dana-Farber Cancer Institute, Inc., an Executive Vice President-Business Development at Exelixis Pharmaceuticals, Inc., a Corporate & Intellectual Property Counsel at Celera Group from 1998 to 2001, a VP-Intellectual Property & Legal Affairs at Zyomyx, Inc., and the Head-Strategic Alliances at Novartis Pharmaceuticals Corp.
from 2003 to 2008 and at Novartis Institutes for Biomedical Research, Inc. from 2003 to 2008.
She was also a Trustee at Bristol-Myers Squibb Foundation from 2012 to 2014.
Ms. Heller's education includes a graduate degree from American University, an undergraduate degree from Tulane University (Louisiana), and a graduate degree from Golden Gate University School of Law.